Growing cases of arthritis in the country is expected to drive the growth of India diclofenac sodium market during the forecast period.
According to TechSci Research report, “India Diclofenac Sodium Market By Product Type (Prescription v/s OTC), By Form (Tablet, Injection, Gel, Others), By Application (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid arthritis, Migraine, Pain and Others), By Route of Administration (Oral, Intravenous, Topical, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026”, the India diclofenac sodium market is expected to grow at a steady rate during the forecast period on account of growing prevalence of arthritis. Also, rising incidence of autoimmune diseases in the country is creating growth opportunities for diclofenac sodium market over the forecast period. Continuous growth in research and developmental activities is projected to fuel the market growth through FY2026. Government initiatives and favorable policies is further expected to positively contribute to the market growth in the forthcoming years. Furthermore, growing awareness about anti-inflammatory therapeutics is making headway for the growth of India diclofenac sodium market in the years to come. However, there are certain factors that might act as major impediments to the growth of India diclofenac sodium market during the forecast period such as side effects of anti-inflammatory drugs and patent expiry issues of drugs. Mounting demand for novel anti-inflammatory therapeutics having lesser side effects coupled with better efficacy are estimated to bode well for market growth in the years to come.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on" India Diclofenac Sodium Market"
The India diclofenac sodium market is segmented based on product type, type, source, form, distribution channel, application, route of administration, company, and region. Based on distribution channel, the market can be fragmented into online v/s offline. The offline channel is expected to dominate the market which is attributable to the fact that consumers prefer buying medicines from a pharmacy or drug store located nearby. The online segment is also expected to register significant growth over the next few years. This can be ascribed to the emergence of several online pharmacies and doorstep drug delivery e-commerce platforms in the country.
Novartis India Ltd, Hetero Drugs Ltd., Auro Laboratories Ltd., Aarti Drugs Ltd., J B Chemicals and Pharmaceuticals Ltd., Novartis India Ltd., Emkay Pharma Pvt. Ltd., Bestochem Formulations (India) Limited, Salvavidas Pharmaceutical Pvt. Ltd., Wellona Pharma Pvt. Ltd, and others are some of the leading players operating in India diclofenac sodium market. The key market players operating in the market are using organic strategies such as product launches, mergers and acquisitions, research collaborations, joint ventures to boost their market share and to expand their geographic reach. Along with this, supportive policy for the pharmaceutical industry is anticipated to aid the current market of diclofenac sodium.
Download Free Sample Report@ https://www.techsciresearch.com/sample-report.aspx?cid=7197
Customers can also request for 10% free customization on this report.
“India diclofenac sodium market is expected to witness steady growth in the coming years on account of rising disorders of the musculo-skeletal system amongst population. During all stages of pain treatment, this drug is usually used in combination with sedatives, antidepressants, and anti-epileptics as diclofenac sodium is most commonly used painkiller. Also, continuous innovation in the field of diclofenac sodium drugs for treating inflammatory pain is another key factor which is expected to create lucrative opportunities for the market growth over the next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“India Diclofenac Sodium Market By Product Type (Prescription v/s OTC), By Form (Tablet, Injection, Gel, Others), By Application (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid arthritis, Migraine, Pain and Others), By Route of Administration (Oral, Intravenous, Topical, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India diclofenac sodium market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India diclofenac sodium market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017